OctoPlus N.V. has received a contract from an existing client to manufacture additional drug product. The contract value will make a material contribution to OctoPlus’ annual revenues in 2012. Financial details were not disclosed. OctoPlus provides formulation development and clinical material manufacturing services to pharma and biopharma companies worldwide, and offers drug delivery technologies for the development of controlled release versions of existing or new drugs....